Policies related to laboratory developed tests.
Duration: January 1, 2008
to
present
General Issues: Health Issues , Disaster Planning/Emergencies , Budget/Appropriations , Medicare/Medicaid , Medical/Disease Research/Clinical Labs , Government Issues
Spending: about $410,800 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: House of Representatives, U.S. Senate, Natl Institutes of Health (NIH)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies lobbied for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on April 17.
Original Filing: 301551320.xml
Lobbying Issues
Policies related to laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies did no lobbying for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on Jan. 3.
Original Filing: 301521607.xml
3rd Quarter, 2023
In Q3, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies did no lobbying for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on Nov. 17, 2023.
Original Filing: 301519119.xml
2nd Quarter, 2023
In Q2, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies did no lobbying for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on July 20, 2023.
Original Filing: 301487070.xml
1st Quarter, 2023
In Q1, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies lobbied for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on April 12, 2023.
Original Filing: 301450667.xml
Lobbying Issues
Including issues related to the blood supply in the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies did no lobbying for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on Jan. 17, 2023.
Original Filing: 301429239.xml
3rd Quarter, 2022
In Q3, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies did no lobbying for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on Oct. 19, 2022.
Original Filing: 301408705.xml
2nd Quarter, 2022
In Q2, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies did no lobbying for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on July 20, 2022.
Original Filing: 301389092.xml
1st Quarter, 2022
In Q1, American Association of Blood Banks, dba Association for the Advancement of Blood & Biotherapies lobbied for American Association of Blood Banks, dba Association for the Advancement of Bloo . The report was filed on April 18, 2022.
Original Filing: 301359069.xml
Lobbying Issues
Supporting policies intended strengthen the blood supply.
Lobbying Issues
The "Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act" or the "PREVENT Pandemics Act" (S. 3799) on issues pertaining to the blood supply.
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Appropriations for National Institutes of Health in a FY 2022 omnibus appropriation bill.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 19, 2022.
Original Filing: 301328111.xml
Lobbying Issues
Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 18, 2021.
Original Filing: 301301250.xml
Lobbying Issues
-Advancing policies that support the blood supply.
-Cures 2.0 discussion draft and Advanced Research Projects Agency for Health (ARPA-H) request for information.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care.
Supporting a bill that would authorize the Centers for Medicare and Medicaid Services (CMS) to develop a program for Medicaid beneficiaries to improve access to comprehensive outpatient care for individuals with sickle cell disease.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 14, 2021.
Original Filing: 301276282.xml
Lobbying Issues
Advancing policies that support the blood supply.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for the Center for Biologics Evaluation and Research at the Food and Drug Administration in the FY 2022 appropriations bill for the Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.
Appropriations for implementation of section 3226 of the Coronavirus Aid, Relief, and
Economic Security Act (P.L. 116-136)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support for innovative payment models for novel biotherapies.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 29, 2021.
Original Filing: 301269901.xml
Lobbying Issues
Advancing policies that support the blood supply.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for National Institutes of Health and the Centers for Disease Control and Prevention in the FY 2022 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301235813.xml
Lobbying Issues
Support for (1) research and activities related to blood donor awareness and engagement; (2) a data infrastructure that capture real-time data on the blood supply; and (3) a public-private partnership to advance policy solutions for the U.S. blood system.
3rd Quarter, 2020
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) did no lobbying for itself. The report was filed on Oct. 14, 2020.
Original Filing: 301209442.xml
2nd Quarter, 2020
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) did no lobbying for itself. The report was filed on July 17, 2020.
Original Filing: 301192042.xml
1st Quarter, 2020
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 16, 2020.
Original Filing: 301168450.xml
Lobbying Issues
Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) on issues pertaining to the blood supply.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 16, 2020.
Original Filing: 301107353.xml
Lobbying Issues
Support for the Patient Access to Cellular Transplant (PACT) Act (S. 1286/H.R. 2498).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) did no lobbying for itself. The report was filed on Oct. 15, 2019.
Original Filing: 301065492.xml
2nd Quarter, 2019
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 22, 2019.
Original Filing: 301056534.xml
Lobbying Issues
Appropriations for the Food and Drug Administration in the fiscal year 2020 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies bill.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 15, 2019.
Original Filing: 301025468.xml
Lobbying Issues
Request that the Senate advance the Pandemic and All-Hazards Preparedness Advancing Innovation Act (PAHPAI, H.R. 269).
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Appropriations for National Institutes of Health in the FY 2020 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 18, 2019.
Original Filing: 301007560.xml
Lobbying Issues
The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2018
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 18, 2018.
Original Filing: 300988023.xml
Lobbying Issues
The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2018
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 16, 2018.
Original Filing: 300965477.xml
Lobbying Issues
Letter to Congress supporting the Food and Drug Administration's process related to a pending guidance entitled,Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Appropriations for certain preparedness programs in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 and House bill reauthorizing the Pandemic and All-Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2018
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 16, 2018.
Original Filing: 300945305.xml
Lobbying Issues
Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 (H.R. 2410/ S. 2465), which would reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
Appropriations for National Institutes of Health in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.
Appropriations for the expansion of the C.W. Bill Young Transplantation Program's Stem Cell Outcomes Database to enable the creation of a national registry for regenerative cell therapies in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.
Appropriations for certain preparedness programs in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of the Pandemic and All-Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2017
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 16, 2018.
Original Filing: 300924401.xml
Lobbying Issues
H.R. 4215 (Protect Access to Cellular Transplant (PACT) Act), which would require Medicare to make separate payments to hospitals to cover costs associated with donor search and acquisition for hematopoietic cell transplantation.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
3rd Quarter, 2017
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) did no lobbying for itself. The report was filed on Oct. 16, 2017.
Original Filing: 300904125.xml
2nd Quarter, 2017
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 12, 2017.
Original Filing: 300883795.xml
Lobbying Issues
Appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2017
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 14, 2017.
Original Filing: 300865688.xml
Lobbying Issues
Appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2017
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 9, 2017.
Original Filing: 300844402.xml
Lobbying Issues
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325
Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
3rd Quarter, 2016
AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) amended a lobbying report for in-house lobbying in Q32016 on Oct. 13, 2016
Original Filing: 300827100.xml
Lobbying Issues
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325
Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
3rd Quarter, 2016
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 11, 2016.
Original Filing: 300826275.xml
Lobbying Issues
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325
Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
2nd Quarter, 2016
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 16, 2016.
Original Filing: 300810976.xml
Lobbying Issues
appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2017 (S 3040)
Zika Response Appropriations Act (HR 5243)
Agencies Lobbied
U.S. Senate
Lobbying Issues
blood safety issues;
Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act, S 2689, HR4762;
21st Century Cures Act, HR 6
Agencies Lobbied
U.S. Senate
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug administration regulation of blood products, devices and cellular therapies
Reliable and Effective Growth for Regenerative Health Options that Improve Health (REGROW) Act, S 2689, HR 4762
21st Century Cures Act, HR 6;
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 20, 2016.
Original Filing: 300801830.xml
Lobbying Issues
appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2017
Lobbying Issues
blood safety issues;
Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act, S 2689, HR4762;
21st Century Cures Act, HR 6
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug administration regulation of blood products, devices and cellular therapies
Reliable and Effective Growth for Regenerative Health Options that Improve Health (REGROW) Act, S 2689, HR 4762
21st Century Cures Act, HR 6;
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 21, 2016.
Original Filing: 300784861.xml
Lobbying Issues
appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2016, HR 3020, S 1695 S 2132
Lobbying Issues
blood safety issues;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820;
21st Century Cures Act, HR 6
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug administration regulation of blood products, devices and cellular therapies
21st Century Cures Act, HR 6;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) amended a lobbying report for in-house lobbying in Q32015 on Nov. 23, 2015
Original Filing: 300767938.xml
Lobbying Issues
appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2016, HR 3020 and S 1695
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
blood safety issues;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820;
21st Century Cures Act, HR 6
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug administration regulation of blood products, devices and cellular therapies
21st Century Cures Act, HR 6;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300759569.xml
Lobbying Issues
appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2016, HR 3020 and S 1695
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
blood safety issues;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820;
21st Century Cures Act, HR 6
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug administration regulation of blood products, devices and cellular therapies
21st Century Cures Act, HR 6;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2015
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 20, 2015.
Original Filing: 300742714.xml
Lobbying Issues
appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2016, HR 3020 and S 1695
Appropriations for blood safety programs under the President's Emergency Plan for AIDS Relief (PEPFAR) in the Department of State and Foreign Operations in 2016
Lobbying Issues
blood safety issues;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820;
21st Century Cures Act, HR 6
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug administration regulation of blood products, devices and cellular therapies
21st Century Cures Act, HR 6;
Stem Cell Therapeutic and Research Reauthorization Act of 2015, HR 2820
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2015
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 23, 2015.
Original Filing: 300728631.xml
Lobbying Issues
appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2016
Appropriations for blood safety programs under the President's Emergency Plan for AIDS Relief (PEPFAR) in the Department of State and Foreign Operations in 2016
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug administration regulation of blood products, devices and cellular therapies
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2014
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 28, 2015.
Original Filing: 300709787.xml
Lobbying Issues
Appropriations for National Institutes of Health in the Department of Labor, HHS, Education and Related Agencies Appropriations Act of 2015
Lobbying Issues
blood safety issues;
H.R. 5539, To amend title XI of the Social Security Act to exempt from manufacturer
transparency reporting certain transfers used for educational purposes,
and for other purposes
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
Lobbying Issues
Food and Drug Administration regulation of blood products, devices and cellular therapies.
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2014
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300685586.xml
Lobbying Issues
appropriations for National Institutes of Health in the Department of Labor, HHS, Education and Related Agencies Appropriations Act 0f 2015
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
2nd Quarter, 2014
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 20, 2014.
Original Filing: 300663838.xml
Lobbying Issues
Appropirations for National Insitutes of Health in the Department of Labor, HHS, Education and Related Agencies Appropriations Act of 2015
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
1st Quarter, 2014
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 14, 2014.
Original Filing: 300635597.xml
Lobbying Issues
Appropriations for National Institutes of Health in the Department of Labor, HHS, Education and Related Agencies Appropriations Act 0f 2015
Lobbying Issues
Blood Safety issues; H.Con.Res.80 - "Expressing support for designation of January 2014 as "National Blood Donor Month"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
4th Quarter, 2013
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 22, 2014.
Original Filing: 300627134.xml
Lobbying Issues
Appropriations for National Institutes of Health in the Department of Labor, HHHS, Education and Related Agencies Appropriations Act of 2014 (S 1284)
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Medicare reimbursement for transfusion medicine and cellular therapies
3rd Quarter, 2013
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 24, 2013.
Original Filing: 300608449.xml
Lobbying Issues
Appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2014 (S 1284)
Lobbying Issues
disaster preparedness for blood supply
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2013
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 25, 2013.
Original Filing: 300587376.xml
Lobbying Issues
Appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and RElated Agencies Appropriations Act of 2014.
Lobbying Issues
Disaster preparedness for blood supply
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2013
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on May 2, 2013.
Original Filing: 300567744.xml
Lobbying Issues
Appropriations for National Institutes of Health
Lobbying Issues
Disaster preparedness for blood supply
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2012
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 22, 2013.
Original Filing: 300541895.xml
Lobbying Issues
Appropriations for blood safety surveillance (hemovigilance) program at Department of Health and Human Services in Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2013 (S. 3295)
Lobbying Issues
S. 3391/H.R. 6118 -- Taking Essential Steps for Testing Act -- legialation regarding Medicare sanctions for proficiency testing
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
S. 3391/H.R. 6118 -- Taking Essential Steps for Testing Act -- legislation regarding Medicare sanctions for proficiency testing
Lobbying Issues
Disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2012
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 23, 2012.
Original Filing: 300521916.xml
Lobbying Issues
Appropriations for blood safety surveillance (hemovigilance) program at Department of Health and Human Services in Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2013 (S. 3295)
Lobbying Issues
H.R. 6272, Trial and Experimental Studies Transparency Act
S. 3391/H.R. 6118 -- Taking Essential Steps for Testing Act -- legislation regarding Medicare sanctions for proficiency testing referrals
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
S. 3391/H.R. 6118 -- Taking Essential Steps for Testing Act -- legislation regarding Medicare sanctions for proficiency testing referrals
Medicare reimbursement for blood, transfusion medicine and cellular therapies.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
provisions to limit federal employee attendance at private association meetings in H.R. 2146, Digital Accountability and Transparency Act of 2012, and S. 1789, 21st Century Postal Service Act of 2012
2nd Quarter, 2012
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Aug. 1, 2012.
Original Filing: 300501181.xml
Lobbying Issues
Appropriations for blood safety surveillance (hemovigilance) program at Department of Health and Human Services in Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2013 (S. 3295)
Lobbying Issues
Appropriations for the National Institutes of Health within Departments of Labor, Health and Human Services, Education and Related Agencies Act of 2013 (S. 3295)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
provisions to limit federal employee attendance at private association meetings in HR 2146, Digital Accountability and Transparency Act of 2012, and S 1789, 21st Century Postal Service Act of 2012
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 19, 2012.
Original Filing: 300468198.xml
Lobbying Issues
Appropriations for blood safety surveillance (hemovigilance) program at the Centers for Disease Control and Prevention in Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2013
Lobbying Issues
appropriations for the National Heart, Lung and Blood Insitute within Departments of Labor, Health and Human Services, Education and Related Agencies Act of 2013
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2011
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300451878.xml
Lobbying Issues
appropriations for blood safety surveillance (hemovigilance) program at the Centers for Disease Control and Prevention in Departments of Labor, HHS, Education and Related Agencies Appropriations
Lobbying Issues
appropriations for the National Heart, Lung and Blood Institute within the Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2011
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Dec. 21, 2011.
Original Filing: 300433700.xml
Lobbying Issues
Appropriations for blood safety surveillance (hemovigilance) program at the Centers for Disease Control and Prevention in S. 1599, Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2012
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
appropriations for the National Heart, Lung, and Blood Institute within S. 1599, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act of 2012
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2011
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 21, 2011.
Original Filing: 300406640.xml
Lobbying Issues
Appropriations for blood safety surveillance (hemovigilance program at the Centers for Disease Control and Prevention
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
appropriations for the National Heart, Lung and Blood Institute included in the 2012 Labor, HHS, and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2011
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 13, 2011.
Original Filing: 300363258.xml
Lobbying Issues
Appropriations for blood safety surveillance (hemovigilance) program at the Centers for Disease Control and Prevention under the 2011 Labor, HHS and Education Appropriations bill (S 3686) and 2012 Labor, HHS and Education Appropriations bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 3686, appropriations for the National Heart, Lung and Blood Institute included in the FY 2011 Labor, HHS and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2010
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 20, 2011.
Original Filing: 300348286.xml
Lobbying Issues
S. 3686, Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention and funding for AABB under the 2011Labor, HHS and Education Appropriations bill;
S. 3676, appropriations for the President's Emergency Plan for AIDS Relief under the FY 2011 State and Foreign Operations Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 3686, appropriations for the National Heart, Lung and Blood Institute included in the FY 2011 Labor, HHS and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2010
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 20, 2010.
Original Filing: 300327641.xml
Lobbying Issues
blood safety issues
S. 3751, Stem Cell Therapeutic and Research Reauthorization Act of 2005
Lobbying Issues
S 3686, Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention and funding for AABB under the 2011 Labor, HHS and Education Appropriations bill;
S 3676, appropriations for the President's Emergency Program fo AIDS Relief under the FY 2011 State and Foreign Operations Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S 3686, appropriations for the National Heart, Lung and Blood Institute included in teh FY 2011 Labor, HHS and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2010
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300301877.xml
Lobbying Issues
blood safety issues
Reauthorization of the C.W. Bill Young Stem Cell Transplantation Program and the National Cord Blood Inventory
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention and funding for AABB under the FY 2011 Labor, HHS and Education Appropriations bill;
Appropriations for the President's Emergency Program for AIDS Relief under the FY 2011 State and Foreign Operations Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for the National Heart, Lung and Blood Institute included in the FY 2011 Labor, HHS and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2010
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300269469.xml
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention and funding for AABB under the FY 2011 Labor, HHS and Education Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for the National Heart, Lung and Blood Institute included in the FY 2011 Labor, HHS and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
Disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2009
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300245452.xml
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention in FY 2010 Labor, HHS and Education Appropriations bill (HR 3293)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for the National Heart, Lung and Blood Institute included in the FY 2010 Labor, HHS and Education Appropriations bill (HR 3293)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
Disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2009
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300217609.xml
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention in FY 2010 Labor, HHS, Education Appropriations bill (HR 3293)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for the National, Heart, Lung and Blood Institute included in the FY 2010 Labor, HHS and Education Appropriations bill (HR 3293)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
Disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2009
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300192324.xml
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention in FY 2010 Labor, HHS, Education Appropriations Bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for the National, Heart, Lung and Blood Institute included in the FY 2010 Labor, HHS and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
Disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2009
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300161796.xml
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention in FY2010 Labor, HHS, Education Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for the National Heart, Lung and Blood Institute included in the FY 2010 Labor, HHS and Education Appropriations bill
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2008
In Q4, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300132310.xml
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention in the FY 2009 Labor, HHS, Education Appropriations bill (S 3230)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
appropriations for the National Heart, Lung and Blood Institute included in the FY 2009 Labor, HHS and Education Appropriations bill (S 3230)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2008
In Q3, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on Oct. 19, 2008.
Original Filing: 300100778.xml
Lobbying Issues
Blood Safety Issues
Blood Safety Initiatives in reauthorization of the President's Emergency Plan for AIDS Relief (HR5501, S2731)
Cord blood and stem cell issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Biomedical research funding at the National Heart, Lung and Blood Institute
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2008
In Q2, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300079776.xml
Lobbying Issues
Blood Safety Issues
Blood Safety Initiatives in reauthorization of the President's Emergency Plan for AIDS Relief (HR5501, S2731)
Lobbying Issues
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Biomedical research funding at the National Heart, Lung and Blood Institute
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies.
Lobbying Issues
Disaster preparedness for the blood supply.
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2008
In Q1, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB) had in-house lobbyists. The report was filed on April 23, 2008.
Original Filing: 300056769.xml
Lobbying Issues
Blood safety issues
Blood safety initiatives in reauthorization of President's Emergency Program for AIDS Relief (HR5501, S2731)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Biomedical research funding at National Heart, Lung and Blood Institute
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare reimbursement for blood, transfusion medicine and cellular therapies
Lobbying Issues
Appropriations for President's Emergency Program for AIDS Relief
Appropriations for blood safety surveillance program at the Centers for Disease Control and Prevention
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Disaster preparedness for the blood supply
Type of Issue
Disaster Planning/Emergencies
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...